Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

"Given the pace of AI innovation, we are confident that this is not a distant dream, but a reality that will unfold in the ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical ...

AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging field of treatments that can reprogramme immune cells inside patients ...

Hong Kong stocks advanced along with major regional equity markets after a US court blocked President Donald Trump’s sweeping ...

In a revolutionary leap for neonatal healthcare, researchers from the Critical Analytics for Manufacturing ...

Room rent in Singapore is usually calculated on a monthly basis and depends on factors like location, property type (HDB flat or condominium), room size, and whether the unit is furnished. Utilities ...

The Singapore Teaching and Academic Research Talent (START) Scheme is co-funded by the Ministry of Education (MOE) and SIT to encourage and support outstanding young Singaporeans interested in ...

May 27, 2025 — Scientists have discovered cells in the skin of Atlantic salmon that offer new insights into how wounds heal, tissues regenerate, and cellular transitions support long-term skin ...

The Singapore Teaching and Academic Research Talent (START) Scheme is co-funded by the Ministry of Education (MOE) and SIT to encourage and support outstanding young Singaporeans interested in ...

Novo Nordisk has reached an agreement to buy Germany’s Cardior Pharmaceuticals for €1.025 billion ($1.1 billion), adding expertise in RNA therapeutics and a heart failure therapy in mid-stage ...